Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study)
13/05/2025
Aymon, R., et al. (JAK-pot collaboration)
Arthritis Rheumatol. 2025 Apr 15. doi: 10.1002/art.43188.
https://doi.org/10.1002/art.43188
doi: 10.1002/art.43188